Machine Learning and AI for Advancing Science in Drug Discovery and Development
Date:
This presentation explores how machine learning (ML) and artificial intelligence (AI) are transforming drug discovery and development at AstraZeneca. It covers the scientific, operational, and ethical dimensions of AI adoption, highlights real-world use cases across the R&D pipeline, and discusses the future direction of agentic AI in biopharma.
Presented at the ELLIS Summer School on Machine Learning for Healthcare and Biology, 28 May 2025